University of Southern California clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

1. Notable

   Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of…Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

   Primary completion pushed from Aug 12, 2026 to Mar 31, 2027

   Also in this update: Study completion pushed from Aug 12, 2027 to Mar 31, 2028

   University of Southern California·Phase 1· NCT04387084· Registry history of NCT04387084 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.